Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CYTOSAR-U

CYTARABINE

Standard Dose
500MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CYTOSAR-U is listed in Drugs@FDA under application 075206 (ANDA).

Marketing status: Discontinued Active ingredient CYTARABINE Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor TEVA PHARMS USA Submission history Latest submission status date: 1998-12-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYTOSAR-U is listed in Drugs@FDA under application 075206 (ANDA). Marketing status: Discontinued Active ingredient CYTARABINE Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor TEVA PHARMS USA Submission history Latest submission status date: 1998-12-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.